A citation-based method for searching scientific literature

Zhen Wang, Lei Liu, Ying Li, Zi'an Song, Yi Jing, Ziyu Fan, Sheng Zhang. Front Oncol 2021
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
40

The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
Julio Calvete, Gorka Larrinaga, Peio Errarte, Ana M Martín, Ana Dotor, Cristina Esquinas, Caroline E Nunes-Xavier, Rafael Pulido, José I López, Javier C Angulo. Hum Pathol 2019
27
20

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
Danijel Sikic, Bastian Keck, Sven Wach, Helge Taubert, Bernd Wullich, Peter J Goebell, Andreas Kahlmeyer, Peter Olbert, Philipp Isfort, Wilhelm Nimphius,[...]. PLoS One 2017
20
20

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
20

Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Margit A Huber, Norbert Kraut, John E Park, Roland D Schubert, Wolfgang J Rettig, Ralf U Peter, Pilar Garin-Chesa. J Invest Dermatol 2003
116
20

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.
Artur Mezheyeuski, Ulrika Segersten, Lina Wik Leiss, Per-Uno Malmström, Jiri Hatina, Arne Östman, Carina Strell. Sci Rep 2020
24
20

Biomarkers for cancer-associated fibroblasts.
Chencheng Han, Tongyan Liu, Rong Yin. Biomark Res 2020
55
20

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Peter A Humphrey, Holger Moch, Antonio L Cubilla, Thomas M Ulbright, Victor E Reuter. Eur Urol 2016
844
20

Three differentiation states risk-stratify bladder cancer into distinct subtypes.
Jens-Peter Volkmer, Debashis Sahoo, Robert K Chin, Philip Levy Ho, Chad Tang, Antonina V Kurtova, Stephen B Willingham, Senthil K Pazhanisamy, Humberto Contreras-Trujillo, Theresa A Storm,[...]. Proc Natl Acad Sci U S A 2012
181
20

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Cosima Völkel, Noémi De Wispelaere, Sören Weidemann, Natalia Gorbokon, Maximilian Lennartz, Andreas M Luebke, Claudia Hube-Magg, Martina Kluth, Christoph Fraune, Katharina Möller,[...]. Virchows Arch 2022
1
100

Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Simone Bertz, Wolfgang Otto, Stefan Denzinger, Wolf F Wieland, Maximilian Burger, Robert Stöhr, Stefan Link, Ferdinand Hofstädter, Arndt Hartmann. Eur Urol 2014
67
20


FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Viviana Cremasco, Jillian L Astarita, Angelo L Grauel, Shilpa Keerthivasan, Kenzie MacIsaac, Matthew C Woodruff, Michael Wu, Lotte Spel, Stephen Santoro, Zohreh Amoozgar,[...]. Cancer Immunol Res 2018
93
20

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.
Atif Ali Hashmi, Zubaida Fida Hussain, Muhammad Irfan, Muhammad Muzzammil Edhi, Sarah Kanwal, Naveen Faridi, Amir Khan. BMC Res Notes 2018
15
20

Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Maria Del Carmen Rodriguez Pena, Alcides Chaux, Marie-Lisa Eich, Aline C Tregnago, Diana Taheri, Walaa Borhan, Rajni Sharma, M Katayoon Rezaei, George J Netto. Virchows Arch 2019
24
20

Traditional Classification and Novel Subtyping Systems for Bladder Cancer.
Shaoming Zhu, Weimin Yu, Xiao Yang, Cheng Wu, Fan Cheng. Front Oncol 2020
37
20


Cancer-associated fibroblasts-heroes or villains?
Krystyna A Gieniec, Lisa M Butler, Daniel L Worthley, Susan L Woods. Br J Cancer 2019
102
20


CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective.
Mohammed Akhtar, Sameera Rashid, Mohamed Ben Gashir, Noheir Mostafa Taha, Issam Al Bozom. Adv Urol 2020
6
20


Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
Woonyoung Choi, Andrea Ochoa, David J McConkey, Mattias Aine, Mattias Höglund, William Y Kim, Francisco X Real, Anne E Kiltie, Ian Milsom, Lars Dyrskjøt,[...]. Eur Urol 2017
135
20

Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.
Ali Hussain, Veronique Voisin, Stephanie Poon, Christina Karamboulas, Ngoc Hoang Bao Bui, Jalna Meens, Julia Dmytryshyn, Victor W Ho, Kwan Ho Tang, Joshua Paterson,[...]. J Exp Med 2020
33
20

Fibroblasts in cancer.
Raghu Kalluri, Michael Zeisberg. Nat Rev Cancer 2006
20

Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Kien T Mai, Luan D Truong, Christopher G Ball, Phillip Williams, Trevor A Flood, Eric C Belanger. Pathol Res Pract 2015
10
20

A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
Rania Makboul, Hesham M Hassan, Abeer Refaiy, Islam F Abdelkawi, Ahmed Abdelhamid Shahat, Diaa A Hameed, Aiat Morsy, Tareq Salah, Rabab Ahmed Ahmed Mohammed. Clin Genitourin Cancer 2019
10
20

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Ana Costa, Yann Kieffer, Alix Scholer-Dahirel, Floriane Pelon, Brigitte Bourachot, Melissa Cardon, Philemon Sirven, Ilaria Magagna, Laetitia Fuhrmann, Charles Bernard,[...]. Cancer Cell 2018
633
20

The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.
Adam Skibinski, Jerrica L Breindel, Aleix Prat, Patricia Galván, Elizabeth Smith, Andreas Rolfs, Piyush B Gupta, Joshua LaBaer, Charlotte Kuperwasser. Cell Rep 2014
117
20

A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.
Yael Aylon, Dan Michael, Ayelet Shmueli, Norikazu Yabuta, Hiroshi Nojima, Moshe Oren. Genes Dev 2006
214
20

YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.
Hirofumi Omori, Miki Nishio, Muneyuki Masuda, Yosuke Miyachi, Fumihito Ueda, Takafumi Nakano, Kuniaki Sato, Koshi Mimori, Kenichi Taguchi, Hiroki Hikasa,[...]. Sci Adv 2020
44
20

Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).
Yue Zhao, Wei Zhou, Liyan Xue, Weimin Zhang, Qimin Zhan. PLoS One 2014
22
20

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
20

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
Gemma Molyneux, Felipe C Geyer, Fiona-Ann Magnay, Afshan McCarthy, Howard Kendrick, Rachael Natrajan, Alan Mackay, Anita Grigoriadis, Andrew Tutt, Alan Ashworth,[...]. Cell Stem Cell 2010
504
20

Down-regulation of LATS kinases alters p53 to promote cell migration.
Noa Furth, Noa Bossel Ben-Moshe, Yair Pozniak, Ziv Porat, Tamar Geiger, Eytan Domany, Yael Aylon, Moshe Oren. Genes Dev 2015
51
20

HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Lisha Xiang, Daniele M Gilkes, Hongxia Hu, Weibo Luo, John W Bullen, Houjie Liang, Gregg L Semenza. Oncotarget 2015
51
20

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
J Gudmundsson, R B Barkardottir, G Eiriksdottir, T Baldursson, A Arason, V Egilsson, S Ingvarsson. Br J Cancer 1995
92
20

Targeting the Hippo signalling pathway for cancer treatment.
Keisuke Nakatani, Tomohiko Maehama, Miki Nishio, Hiroki Goto, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki. J Biochem 2017
33
20

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Qun-Ying Lei, Heng Zhang, Bin Zhao, Zheng-Yu Zha, Feng Bai, Xin-Hai Pei, Shimin Zhao, Yue Xiong, Kun-Liang Guan. Mol Cell Biol 2008
689
20

Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates.
O Yalcin-Ozuysal, M Fiche, M Guitierrez, K-U Wagner, W Raffoul, C Brisken. Cell Death Differ 2010
113
20

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
20

How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.
Matthew R Swiatnicki, Eran R Andrechek. J Mammary Gland Biol Neoplasia 2019
4
25

Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway.
Miki Nishio, Tomohiko Maehama, Hiroki Goto, Keisuke Nakatani, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki. Genes Cells 2017
16
20

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies.
Antonio Marra, Dario Trapani, Giulia Viale, Carmen Criscitiello, Giuseppe Curigliano. NPJ Breast Cancer 2020
74
20

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
20

p53 in breast cancer subtypes and new insights into response to chemotherapy.
Philippe Bertheau, Jacqueline Lehmann-Che, Mariana Varna, Anne Dumay, Brigitte Poirot, Raphaël Porcher, Elisabeth Turpin, Louis-François Plassa, Anne de Roquancourt, Edwige Bourstyn,[...]. Breast 2013
130
20

A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.
Preeti M Ismail, Jie Li, Francesco J DeMayo, Bert W O'Malley, John P Lydon. Mol Endocrinol 2002
116
20

LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.
Kenta Masuda, Tatsuyuki Chiyoda, Naoyuki Sugiyama, Aldo Segura-Cabrera, Yasuaki Kabe, Arisa Ueki, Kouji Banno, Makoto Suematsu, Daisuke Aoki, Yasushi Ishihama,[...]. PLoS One 2015
11
20


Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome.
Jane D Holland, Balázs Györffy, Regina Vogel, Klaus Eckert, Giovanni Valenti, Liang Fang, Philipp Lohneis, Sefer Elezkurtaj, Ulrike Ziebold, Walter Birchmeier. Cell Rep 2013
60
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.